Roivant Provides Update on Graves’ Disease Development Program
Go back to Roivant Provides Update on Graves’ Disease Development Program| (NASDAQ: ROIV) | Delayed: 39.98 +0.41 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.57 | 52 Week High | $ | |||
| Open | $40.44 | 52 Week Low | $ | |||
| Day High | $40.97 | P/E | N/A | |||
| Day Low | $39.50 | EPS | $ | |||
| Volume | 7,603,980 | |||||

